Clinical effectiveness and cost-effectiveness of Oncotype DX and Prosigna genetic testing in early-stage breast cancer
IHE
Record ID 32018014293
English
Details
Project Status:
Completed
Year Published:
2019
URL for published report:
https://ihe.ca/document/clinical-effectiveness-and-cost-effectiveness-of-oncotype-dx-and-prosigna-genetic-testing-in-early-stage-breast-cancer/
English language abstract:
An English language summary is available
Publication Type:
Full HTA
Country:
Canada
MeSH Terms
- Breast Neoplasms
- Genetic Testing
- Biomarkers, Tumor
- Gene Expression Profiling
- Neoplasm Staging
Contact
Organisation Name:
Institute of Health Economics
Contact Address:
1200, 10405 – Jasper Avenue, Edmonton, AB T5J 3N4, Canada. Tel: +1 780 448 4881 Fax: +1 780 448 0018
Contact Name:
info@ihe.ca
Contact Email:
info@ihe.ca
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.